P

ProKidney Corp
NASDAQ:PROK

Watchlist Manager
ProKidney Corp
NASDAQ:PROK
Watchlist
Price: 2.57 USD 2.8% Market Closed
Market Cap: 773.1m USD

Wall Street
Price Targets

PROK Price Targets Summary
ProKidney Corp

Wall Street analysts forecast PROK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PROK is 6.85 USD with a low forecast of 1.01 USD and a high forecast of 12.6 USD.

Lowest
Price Target
1.01 USD
61% Downside
Average
Price Target
6.85 USD
166% Upside
Highest
Price Target
12.6 USD
390% Upside
ProKidney Corp Competitors:
Price Targets
PRME
Prime Medicine Inc
89% Upside
ARMP
Armata Pharmaceuticals Inc
43% Upside
TVTX
Travere Therapeutics Inc
5% Upside
1801
Innovent Biologics Inc
33% Upside
2157
Lepu Biopharma Co Ltd
106% Upside
301080
Acrobiosystems Co Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
ProKidney Corp

The compound annual growth rate of ProKidney Corp's revenue for the next 4 years is 699%.

N/A
Past Growth
699%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ProKidney Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
ProKidney Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PROK's stock price target?
Price Target
6.85 USD

According to Wall Street analysts, the average 1-year price target for PROK is 6.85 USD with a low forecast of 1.01 USD and a high forecast of 12.6 USD.

What is ProKidney Corp's Revenue forecast?
Projected CAGR
699%

The compound annual growth rate of ProKidney Corp's revenue for the next 4 years is 699%.

Back to Top